Tesla Inc(NASDAQ:TSLA): Asked about limitations of EV in transportation… Musk: Absolutely confident that electric vehicles will occupy every segment of the transportation industry; everything except for rockets (ironic because of SpaceX) Have seen evidence that

Peregrine Pharmaceuticals(NASDAQ:PPHM) announces presentation of preclinical study results; latest findings from ongoing collaboration with memorial sloan kettering support potential applications for combining car t and anti-ps in treatment of solid tumors  (0.65) For this study,

UBS initiates Amgen, Inc.(NASDAQ:AMGN ) with a Neutral and price target of $185. During the next four years Amgen sales growth will face intensifying headwinds to Enbrel and key legacy products. The late-stage pipeline,

Juno Therapeutics Inc(NASDAQ:JUNO) discontinues development of JCAR015 in r/r adult ALL to focus on defined cell product in this setting   (25.31 +1.27) “We continue to experience encouraging signs of clinical benefit in our trial addressing